- Home
- ->
- Industry News
Dec 04, 2014: "The comparison of clinical effectiveness is always our primary goal. Cost will come as secondary in our decision-making process.”
Outside link:
U.S. spending on specialty drugs, is expected to rise by 19% in 2014